Research Article
RP-HPLC Method for Determination of Several NSAIDs and Their Combination Drugs
Table 9
Quantitative determination in pharmaceutical formulations.
| Formulation examined | API | Label claim (mg) | Amount found (Mean ± SD) (mg) | Recovery (%) | RSD (%) () |
| CLAVIX-AS tab | CLP | 75 | | 100.17 | 0.14 | ASP | 150 | | 100.03 | 0.32 |
| DEXA-P tab | PCM | 125 | | 99.92 | 0.21 | CPM | 1 | | 98.97 | 1.7 | DXM | 5 | | 101.48 | 1.81 |
| THIOCECLO tab | ACF | 100 | | 99.92 | 0.32 | THC | 4 | | 100.33 | 1.37 |
| CETADOM tab | PCM | 500 | | 99.92 | 0.16 | DOM | 10 | | 100.33 | 0.9 |
| MILFLOX PLUS eye drops | MCX | 5 | | 98.4 | 1.74 | KTL | 5 | | 101 | 1.62 |
| SUPAMOVE-4 cap | THC | 4 | | 100.4 | 1.76 | DCF | 50 | | 99.39 | 0.58 |
| ARTIGESIC tab | IBU | 400 | | 99.84 | 0.31 | PCM | 325 | | 100.06 | 0.27 |
| NUCOXIA-P tab | ETC | 60 | | 99.84 | 0.53 | PCM | 500 | | 100.04 | 0.12 |
| NAPRA-D tab | NPX | 250 | | 99.89 | 0.16 | DOM | 10 | | 99.76 | 1.73 |
|
|